LearnReta GLP-3 vs Tirzepatide GLP-2
Research overview
Reta GLP-3 vs Tirzepatide GLP-2
Retatrutide vs tirzepatide
Two metabolic listings: retatrutide with a 20mg/30mg size picker, and a 20mg tirzepatide vial. Catalog framing, not a prescription comparison.
These overviews are product information for laboratory and research use. They are not medical advice, not a protocol, and not a claim that any listing diagnoses, treats, cures, or prevents disease.
Two metabolic listings, two compound names
This catalog lists retatrutide as Reta GLP-3 — a lyophilized research vial with a size picker for 20mg and 30mg. It lists tirzepatide as Tirzepatide GLP-2, a single 20mg vial. Both sit in Metabolic. They are separate SKUs. Neither is a compounding-pharmacy fill, a weight-loss prescription, or a substitute for the other.
Longer single-compound notes: What is retatrutide? and What is Tirzepatide GLP-2?. This page is only a catalog comparison.
How research catalogs group the pathways
Shop copy on both product pages names similar browse angles — appetite control, weight, and metabolic support — because both vials live in the same group. Literature around the compounds is not the same story. Research writeups often describe tirzepatide around dual GIP and GLP-1 receptor models, and retatrutide around a triple angle that also includes a glucagon-receptor model. That is how papers and catalogs cluster the names. It is not a claim that either listing treats diabetes, obesity, or any disease, and it is not a protocol for using one instead of the other.
The product pages list those high-level research angles as product information. They are not diet plans, blood-sugar programs, or dosing instructions. We do not tell you which vial “works better.”
When a shopper might open one vs the other
Someone browsing this catalog might open Reta GLP-3 when they want the retatrutide listing and a choice of 20mg or 30mg on one card. They might open Tirzepatide GLP-2 when they want the tirzepatide listing at 20mg. Those are shop reasons — compound name and listed size — not medical criteria.
Nearby metabolic vials (Tesamorelin, CJC-1295 with DAC, MOTS-C, 5-Amino-1MQ) are different listings again. This comparison does not tell you to combine any of them.
Testing, COA, and research-use notes
Both listings are Janoshik tested. We do not print a purity percentage or a lot number on the product page. How research peptides are supplied and how to read a COA explain what we will and will not publish. Storage stays high-level: cool, dry, away from light. We do not provide mixing, reconstitution, or dosing instructions.
Checkout questions live on the FAQ. Delivery is on Shipping. Policies restates research use. Inquire about Reta GLP-3 or Tirzepatide GLP-2. More notes: research overviews.
Related listings
Catalog cards for the compounds in this overview. Each page repeats the research-use note.
This is product information, not medical advice, and not a prescription. Nothing here diagnoses, treats, cures, or prevents disease. Talk with a licensed clinician before using any peptide or booster.